Stockreport

Cellect Biotechnology Reports Clinical and Regulatory Milestone Targets

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF TEL AVIV, Israel, Jan. 23, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a novel regenerative and cell therapy company with production technology, [Read more]